|
1
|
Elert E: Living with leukaemia. Nature.
498:S2–S3. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
O'Donnell MR, Tallman MS, Abboud CN,
Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE,
Damon LE, et al: Acute myeloid leukemia, version 2.2013. J Natl
Compr Canc Netw. 11:1047–1055. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deschler B and Lübbert M: Acute myeloid
leukemia: Epidemiology and etiology. Cancer. 107:2099–2107. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saito S, Kotera K, Shigematsu N, Ide A,
Sugimoto N, Horii Z, Hanaoka M, Yamawaki Y and Tamura Y: Structure
of securinine. Tetrahedron. 19:2085–2099. 1963. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen CR, Xia YH, Yao SY, Zhang Q, Wang Y
and Ji ZN: Virosecurinine induces apoptosis by affecting Bcl-2 and
Bax expression in human colon cancer SW480 cells. Pharmazie.
67:351–354. 2012.PubMed/NCBI
|
|
6
|
Beutler JA, Karbon EW, Brubaker AN, Malik
R, Curtis DR and Enna SJ: Securinine alkaloids: A new class of GABA
receptor antagonist. Brain Res. 330:135–140. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Weenen H, Nkunya MH, Bray DH, Mwasumbi LB,
Kinabo LS, Kilimali VA and Wijnberg JB: Antimalarial compounds
containing an alpha, beta-unsaturated carbonyl moiety from
Tanzanian medicinal plants. Planta Med. 56:371–373. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mensah JL, Lagarde I, Ceschin C, Michel G,
Gleye J and Fouraste I: Antibacterial activity of the leaves of
Phyllanthus discoideus. J Ethnopharmacol. 28:129–133. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li M, Han S, Zhang G, Wang Y and Ji Z:
Antiproferative activity and apoptosis-inducing mechanism of
L-securinine on human breast cancer MCF-7 cells. Pharmazie.
69:217–223. 2014.PubMed/NCBI
|
|
10
|
Zhang G, Li M, Han S, Chen D, Wang Y, Ye
W3 and Ji Z: Induction of human chronic myeloid leukemia K562 cell
apoptosis by virosecurinine and its molecular mechanism. Mol Med
Rep. 10:2365–2371. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lima RT, Busacca S, Almeida GM, Gaudino G,
Fennell DA and Vasconcelos MH: MicroRNA regulation of core
apoptosis pathways in cancer. Eur J Cancer. 47:163–174. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fulda S: Modulation of apoptosis by
natural products for cancer therapy. Planta Med. 76:1075–1079.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carnero A, Blanco-Aparicio C, Renner O,
Link W and Leal JF: The PTEN/PI3K/AKT signalling pathway in cancer,
therapeutic implications. Curr Cancer Drug Targets. 8:187–198.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmidt-Kittler O, Zhu J, Yang J, Liu G,
Hendricks W, Lengauer C, Gabelli SB, Kinzler KW, Vogelstein B, Huso
DL and Zhou S: PI3Kα inhibitors that inhibit metastasis.
Oncotarget. 1:339–348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng C, Chen Y, Li D and Li S: Role of
PTEN in leukemia stem cells. Oncotarget. 1:156–160. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kharas MG, Okabe R, Ganis JJ, Gozo M,
Khandan T, Paktinat M, Gilliland DG and Gritsman K: Constitutively
active Akt depletes hematopoietic stem cells and induces leukemia
in mice. Blood. 115:1406–1415. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dancey JE, Bedard PL, Onetto N and Hudson
TJ: The genetic basis for cancer treatment decisions. Cell.
148:409–420. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Castello-Branco MVS, Tavares JF, Silva MS,
Barbosa Filho JM, Anazetti MC, Frungillo L, Haun M, Melo Diniz MF
and Melo PS: Xylodiol from Xylopia langsdorfiana induces apoptosis
in HL60 cells. Rev Bras Farmacogn. 21:1035–1042. 2011. View Article : Google Scholar
|
|
20
|
Subramaniya BR, Srinivasan G, Sadullah SS,
Davis N, Subhadara LB, Halagowder D and Sivasitambaram ND:
Apoptosis inducing effect of plumbagin on colonic cancer cells
depends on expression of COX-2. PLoS One. 6:e186952011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li YC, He SM, He ZX, Li M, Yang Y, Pang
JX, Zhang X, Chow K, Zhou Q, Duan W, et al: Plumbagin induces
apoptotic and autophagic cell death through inhibition of the
PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.
Cancer Lett. 344:239–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nahata A, Saxena A, Suri N, Saxena AK and
Dixit VK: Sphaeranthus indicus induces apoptosis through
mitochondrial-dependent pathway in HL-60 cells and exerts cytotoxic
potential on several human cancer cell lines. Integr Cancer Ther.
12:236–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao L and Vogt PK: Class I PI3K in
oncogenic cellular transformation. Oncogene. 27:5486–5496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sokolosky ML, Stadelman KM, Chappell WH,
Abrams SL, Martelli AM, Stivala F, Libra M, Nicoletti F, Drobot LB,
Franklin RA, et al: Involvement of Akt-1 and mTOR in sensitivity of
breast cancer to targeted therapy. Oncotarget. 2:538–550. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Altman JK, Sassano A and Platanias LC:
Targeting mTOR for the treatment of AML. New agents and new
directions. Oncotarget. 2:510–517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Muranyi AL, Dedhar S and Hogge DE:
Combined inhibition of integrin linked kinase and FMS-like tyrosine
kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells.
Exp Hematol. 37:450–460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Faderl S, Pal A, Bornmann W, Albitar M,
Maxwell D, Van Q, Peng Z, Harris D, Liu Z, Hazan-Halevy I, et al:
Kit inhibitor APcK110 induces apoptosis and inhibits proliferation
of acute myeloid leukemia cells. Cancer Res. 69:3910–3917. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Birkenkamp KU, Geugien M, Schepers H,
Westra J, Lemmink HH and Vellenga E: Constitutive NF-kappaB
DNA-binding activity in AML is frequently mediated by a
Ras/PI3-K/PKB-dependent pathway. Leukemia. 18:103–12. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maiuri MC, Tasdemir E, Criollo A, Morselli
E, Vicencio JM, Carnuccio R and Kroemer G: Control of autophagy by
oncogenes and tumor suppressor genes. Cell Death Differ. 16:87–93.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang FF, Wu DS, Zhang L, Yu YH, Yuan XY,
Li WJ, Chen XP, Zhao XL, Chen FP and Zeng H: Inactivation of PTEN
increases ABCG2 expression and the side population through the
PI3K/Akt pathway in adult acute leukemia. Cancer Lett. 336:96–105.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu Q, Thompson JE and Carroll M: mTOR
regulates cell survival after etoposide treatment in primary AML
cells. Blood. 106:4261–4268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Batista A, Barata JT, Raderschall E,
Sallan SE, Carlesso N, Nadler LM and Cardoso AA: Targeting of
active mTOR inhibits primary leukemia T cells and synergizes with
cytotoxic drugs and signaling inhibitors. Exp Hematol.
39:457–472.e3. 2011. View Article : Google Scholar : PubMed/NCBI
|
